nodes	percent_of_prediction	percent_of_DWPC	metapath
Methylergometrine—migraine—Acetylsalicylic acid—coronary artery disease	0.452	1	CpDpCtD
Methylergometrine—HTR2A—coronary artery disease	0.158	1	CbGaD
Methylergometrine—CYP3A4—Ticagrelor—coronary artery disease	0.0216	0.146	CbGbCtD
Methylergometrine—CYP3A4—Fenofibrate—coronary artery disease	0.0192	0.13	CbGbCtD
Methylergometrine—CYP3A4—Gemfibrozil—coronary artery disease	0.0154	0.104	CbGbCtD
Methylergometrine—CYP3A4—Clopidogrel—coronary artery disease	0.0133	0.0905	CbGbCtD
Methylergometrine—CYP3A4—Eplerenone—coronary artery disease	0.0124	0.0841	CbGbCtD
Methylergometrine—CYP3A4—Enalapril—coronary artery disease	0.011	0.075	CbGbCtD
Methylergometrine—HTR2B—cardial valve—coronary artery disease	0.0108	0.371	CbGeAlD
Methylergometrine—CYP3A4—Ezetimibe—coronary artery disease	0.00859	0.0583	CbGbCtD
Methylergometrine—CYP3A4—Rosuvastatin—coronary artery disease	0.00859	0.0583	CbGbCtD
Methylergometrine—CYP3A4—Simvastatin—coronary artery disease	0.00799	0.0542	CbGbCtD
Methylergometrine—CYP3A4—Lovastatin—coronary artery disease	0.00782	0.053	CbGbCtD
Methylergometrine—CYP3A4—Pravastatin—coronary artery disease	0.00782	0.053	CbGbCtD
Methylergometrine—CYP3A4—Atorvastatin—coronary artery disease	0.00712	0.0483	CbGbCtD
Methylergometrine—CYP3A4—Losartan—coronary artery disease	0.00651	0.0442	CbGbCtD
Methylergometrine—HTR2A—arteriole—coronary artery disease	0.00358	0.122	CbGeAlD
Methylergometrine—HTR2A—pulmonary artery—coronary artery disease	0.00234	0.0802	CbGeAlD
Methylergometrine—HTR2A—sympathetic nervous system—coronary artery disease	0.00228	0.078	CbGeAlD
Methylergometrine—HTR2A—vagus nerve—coronary artery disease	0.00221	0.0756	CbGeAlD
Methylergometrine—HTR2A—vein—coronary artery disease	0.00213	0.073	CbGeAlD
Methylergometrine—HTR2A—autonomic nervous system—coronary artery disease	0.00153	0.0524	CbGeAlD
Methylergometrine—HTR2A—artery—coronary artery disease	0.000868	0.0297	CbGeAlD
Methylergometrine—HTR2A—endothelium—coronary artery disease	0.000733	0.0251	CbGeAlD
Methylergometrine—HTR2B—heart—coronary artery disease	0.000599	0.0205	CbGeAlD
Methylergometrine—HTR2B—cardiovascular system—coronary artery disease	0.000565	0.0194	CbGeAlD
Methylergometrine—HTR2B—blood—coronary artery disease	0.000447	0.0153	CbGeAlD
Methylergometrine—Methysergide—HTR7—coronary artery disease	0.000443	0.192	CrCbGaD
Methylergometrine—Bromocriptine—HTR7—coronary artery disease	0.00033	0.143	CrCbGaD
Methylergometrine—HTR2A—heart—coronary artery disease	0.00032	0.011	CbGeAlD
Methylergometrine—Lisuride—ADRB1—coronary artery disease	0.000305	0.132	CrCbGaD
Methylergometrine—HTR2A—cardiovascular system—coronary artery disease	0.000302	0.0103	CbGeAlD
Methylergometrine—Bromocriptine—ADRB1—coronary artery disease	0.000283	0.123	CrCbGaD
Methylergometrine—HTR2A—blood—coronary artery disease	0.000239	0.00817	CbGeAlD
Methylergometrine—Methysergide—HTR2A—coronary artery disease	0.000223	0.0966	CrCbGaD
Methylergometrine—CYP3A4—blood—coronary artery disease	0.000221	0.00757	CbGeAlD
Methylergometrine—Pergolide—HTR2A—coronary artery disease	0.000206	0.0894	CrCbGaD
Methylergometrine—Hallucination—Lisinopril—coronary artery disease	0.00018	0.00152	CcSEcCtD
Methylergometrine—Abdominal pain—Ezetimibe—coronary artery disease	0.000179	0.00151	CcSEcCtD
Methylergometrine—Palpitations—Losartan—coronary artery disease	0.000179	0.00151	CcSEcCtD
Methylergometrine—Lisuride—HTR2A—coronary artery disease	0.000179	0.0776	CrCbGaD
Methylergometrine—Paraesthesia—Niacin—coronary artery disease	0.000178	0.0015	CcSEcCtD
Methylergometrine—Hypotension—Trandolapril—coronary artery disease	0.000178	0.0015	CcSEcCtD
Methylergometrine—Dyspnoea—Niacin—coronary artery disease	0.000177	0.00149	CcSEcCtD
Methylergometrine—Tachycardia—Captopril—coronary artery disease	0.000177	0.00149	CcSEcCtD
Methylergometrine—Gastrointestinal pain—Simvastatin—coronary artery disease	0.000177	0.00149	CcSEcCtD
Methylergometrine—Hypotension—Enalapril—coronary artery disease	0.000177	0.00149	CcSEcCtD
Methylergometrine—Anaphylactic shock—Perindopril—coronary artery disease	0.000176	0.00149	CcSEcCtD
Methylergometrine—Paraesthesia—Pravastatin—coronary artery disease	0.000176	0.00148	CcSEcCtD
Methylergometrine—Abdominal pain—Eplerenone—coronary artery disease	0.000176	0.00148	CcSEcCtD
Methylergometrine—Dizziness—Acetylsalicylic acid—coronary artery disease	0.000175	0.00148	CcSEcCtD
Methylergometrine—Dyspnoea—Pravastatin—coronary artery disease	0.000174	0.00147	CcSEcCtD
Methylergometrine—Hypotension—Telmisartan—coronary artery disease	0.000174	0.00147	CcSEcCtD
Methylergometrine—Nervous system disorder—Perindopril—coronary artery disease	0.000173	0.00146	CcSEcCtD
Methylergometrine—Chest pain—Losartan—coronary artery disease	0.000172	0.00145	CcSEcCtD
Methylergometrine—Rash—Rosuvastatin—coronary artery disease	0.000172	0.00145	CcSEcCtD
Methylergometrine—Tachycardia—Perindopril—coronary artery disease	0.000172	0.00145	CcSEcCtD
Methylergometrine—Dermatitis—Rosuvastatin—coronary artery disease	0.000172	0.00145	CcSEcCtD
Methylergometrine—Ergotamine—HTR2A—coronary artery disease	0.000172	0.0746	CrCbGaD
Methylergometrine—Anaphylactic shock—Furosemide—coronary artery disease	0.000171	0.00144	CcSEcCtD
Methylergometrine—Abdominal pain—Simvastatin—coronary artery disease	0.000171	0.00144	CcSEcCtD
Methylergometrine—Headache—Rosuvastatin—coronary artery disease	0.000171	0.00144	CcSEcCtD
Methylergometrine—Paraesthesia—Trandolapril—coronary artery disease	0.000171	0.00144	CcSEcCtD
Methylergometrine—Hyperhidrosis—Perindopril—coronary artery disease	0.00017	0.00144	CcSEcCtD
Methylergometrine—Paraesthesia—Enalapril—coronary artery disease	0.00017	0.00143	CcSEcCtD
Methylergometrine—Hypotension—Captopril—coronary artery disease	0.00017	0.00143	CcSEcCtD
Methylergometrine—Dyspnoea—Trandolapril—coronary artery disease	0.000169	0.00143	CcSEcCtD
Methylergometrine—Dyspnoea—Enalapril—coronary artery disease	0.000169	0.00142	CcSEcCtD
Methylergometrine—Tinnitus—Lisinopril—coronary artery disease	0.000169	0.00142	CcSEcCtD
Methylergometrine—Vomiting—Acetylsalicylic acid—coronary artery disease	0.000169	0.00142	CcSEcCtD
Methylergometrine—Nervous system disorder—Furosemide—coronary artery disease	0.000168	0.00142	CcSEcCtD
Methylergometrine—Paraesthesia—Telmisartan—coronary artery disease	0.000168	0.00141	CcSEcCtD
Methylergometrine—Rash—Acetylsalicylic acid—coronary artery disease	0.000167	0.00141	CcSEcCtD
Methylergometrine—Gastrointestinal pain—Valsartan—coronary artery disease	0.000167	0.00141	CcSEcCtD
Methylergometrine—Dermatitis—Acetylsalicylic acid—coronary artery disease	0.000167	0.00141	CcSEcCtD
Methylergometrine—Muscle spasms—Ramipril—coronary artery disease	0.000167	0.00141	CcSEcCtD
Methylergometrine—Dyspnoea—Telmisartan—coronary artery disease	0.000166	0.0014	CcSEcCtD
Methylergometrine—Gastrointestinal pain—Olmesartan—coronary artery disease	0.000166	0.0014	CcSEcCtD
Methylergometrine—Bromocriptine—HTR2A—coronary artery disease	0.000166	0.0719	CrCbGaD
Methylergometrine—Hyperhidrosis—Furosemide—coronary artery disease	0.000166	0.0014	CcSEcCtD
Methylergometrine—Anaphylactic shock—Losartan—coronary artery disease	0.000165	0.00139	CcSEcCtD
Methylergometrine—Hypotension—Perindopril—coronary artery disease	0.000165	0.00139	CcSEcCtD
Methylergometrine—Paraesthesia—Captopril—coronary artery disease	0.000163	0.00137	CcSEcCtD
Methylergometrine—Gastrointestinal pain—Niacin—coronary artery disease	0.000163	0.00137	CcSEcCtD
Methylergometrine—Nausea—Rosuvastatin—coronary artery disease	0.000162	0.00137	CcSEcCtD
Methylergometrine—Diarrhoea—Fenofibrate—coronary artery disease	0.000162	0.00137	CcSEcCtD
Methylergometrine—Nervous system disorder—Losartan—coronary artery disease	0.000162	0.00137	CcSEcCtD
Methylergometrine—Dyspnoea—Captopril—coronary artery disease	0.000162	0.00136	CcSEcCtD
Methylergometrine—Abdominal pain—Valsartan—coronary artery disease	0.000162	0.00136	CcSEcCtD
Methylergometrine—Tachycardia—Losartan—coronary artery disease	0.000161	0.00136	CcSEcCtD
Methylergometrine—Abdominal pain—Olmesartan—coronary artery disease	0.000161	0.00136	CcSEcCtD
Methylergometrine—Hypotension—Furosemide—coronary artery disease	0.00016	0.00135	CcSEcCtD
Methylergometrine—Gastrointestinal pain—Pravastatin—coronary artery disease	0.00016	0.00135	CcSEcCtD
Methylergometrine—Hyperhidrosis—Losartan—coronary artery disease	0.00016	0.00135	CcSEcCtD
Methylergometrine—Diarrhoea—Clopidogrel—coronary artery disease	0.000159	0.00134	CcSEcCtD
Methylergometrine—Diarrhoea—Lovastatin—coronary artery disease	0.000158	0.00133	CcSEcCtD
Methylergometrine—Paraesthesia—Perindopril—coronary artery disease	0.000158	0.00133	CcSEcCtD
Methylergometrine—Nausea—Acetylsalicylic acid—coronary artery disease	0.000158	0.00133	CcSEcCtD
Methylergometrine—Dyspnoea—Perindopril—coronary artery disease	0.000157	0.00132	CcSEcCtD
Methylergometrine—Abdominal pain—Niacin—coronary artery disease	0.000157	0.00132	CcSEcCtD
Methylergometrine—Dizziness—Fenofibrate—coronary artery disease	0.000157	0.00132	CcSEcCtD
Methylergometrine—Gastrointestinal pain—Trandolapril—coronary artery disease	0.000155	0.00131	CcSEcCtD
Methylergometrine—Diarrhoea—Ezetimibe—coronary artery disease	0.000155	0.00131	CcSEcCtD
Methylergometrine—Gastrointestinal pain—Enalapril—coronary artery disease	0.000155	0.0013	CcSEcCtD
Methylergometrine—Abdominal pain—Pravastatin—coronary artery disease	0.000155	0.0013	CcSEcCtD
Methylergometrine—Hypotension—Losartan—coronary artery disease	0.000155	0.0013	CcSEcCtD
Methylergometrine—Dizziness—Clopidogrel—coronary artery disease	0.000154	0.0013	CcSEcCtD
Methylergometrine—Paraesthesia—Furosemide—coronary artery disease	0.000154	0.0013	CcSEcCtD
Methylergometrine—Palpitations—Ramipril—coronary artery disease	0.000154	0.00129	CcSEcCtD
Methylergometrine—Dizziness—Lovastatin—coronary artery disease	0.000153	0.00129	CcSEcCtD
Methylergometrine—Gastrointestinal pain—Telmisartan—coronary artery disease	0.000153	0.00129	CcSEcCtD
Methylergometrine—Diarrhoea—Eplerenone—coronary artery disease	0.000152	0.00128	CcSEcCtD
Methylergometrine—Muscle spasms—Lisinopril—coronary artery disease	0.000151	0.00128	CcSEcCtD
Methylergometrine—Vomiting—Fenofibrate—coronary artery disease	0.000151	0.00127	CcSEcCtD
Methylergometrine—Convulsion—Ramipril—coronary artery disease	0.000151	0.00127	CcSEcCtD
Methylergometrine—Abdominal pain—Trandolapril—coronary artery disease	0.00015	0.00127	CcSEcCtD
Methylergometrine—Dizziness—Ezetimibe—coronary artery disease	0.00015	0.00127	CcSEcCtD
Methylergometrine—Palpitations—Timolol—coronary artery disease	0.00015	0.00127	CcSEcCtD
Methylergometrine—Abdominal pain—Enalapril—coronary artery disease	0.00015	0.00126	CcSEcCtD
Methylergometrine—Rash—Fenofibrate—coronary artery disease	0.000149	0.00126	CcSEcCtD
Methylergometrine—Dermatitis—Fenofibrate—coronary artery disease	0.000149	0.00126	CcSEcCtD
Methylergometrine—Headache—Fenofibrate—coronary artery disease	0.000148	0.00125	CcSEcCtD
Methylergometrine—Paraesthesia—Losartan—coronary artery disease	0.000148	0.00125	CcSEcCtD
Methylergometrine—Gastrointestinal pain—Captopril—coronary artery disease	0.000148	0.00125	CcSEcCtD
Methylergometrine—Vomiting—Clopidogrel—coronary artery disease	0.000148	0.00125	CcSEcCtD
Methylergometrine—Diarrhoea—Simvastatin—coronary artery disease	0.000148	0.00125	CcSEcCtD
Methylergometrine—Chest pain—Ramipril—coronary artery disease	0.000148	0.00125	CcSEcCtD
Methylergometrine—Abdominal pain—Telmisartan—coronary artery disease	0.000148	0.00124	CcSEcCtD
Methylergometrine—Dyspnoea—Losartan—coronary artery disease	0.000147	0.00124	CcSEcCtD
Methylergometrine—Vomiting—Lovastatin—coronary artery disease	0.000147	0.00124	CcSEcCtD
Methylergometrine—Dizziness—Eplerenone—coronary artery disease	0.000147	0.00124	CcSEcCtD
Methylergometrine—Rash—Clopidogrel—coronary artery disease	0.000147	0.00124	CcSEcCtD
Methylergometrine—Dermatitis—Clopidogrel—coronary artery disease	0.000147	0.00124	CcSEcCtD
Methylergometrine—Hypertension—Timolol—coronary artery disease	0.000147	0.00124	CcSEcCtD
Methylergometrine—Headache—Clopidogrel—coronary artery disease	0.000146	0.00123	CcSEcCtD
Methylergometrine—Rash—Lovastatin—coronary artery disease	0.000146	0.00123	CcSEcCtD
Methylergometrine—Dermatitis—Lovastatin—coronary artery disease	0.000146	0.00123	CcSEcCtD
Methylergometrine—Headache—Lovastatin—coronary artery disease	0.000145	0.00122	CcSEcCtD
Methylergometrine—Chest pain—Timolol—coronary artery disease	0.000145	0.00122	CcSEcCtD
Methylergometrine—Vomiting—Ezetimibe—coronary artery disease	0.000144	0.00122	CcSEcCtD
Methylergometrine—Gastrointestinal pain—Perindopril—coronary artery disease	0.000144	0.00122	CcSEcCtD
Methylergometrine—Abdominal pain—Captopril—coronary artery disease	0.000144	0.00121	CcSEcCtD
Methylergometrine—Dizziness—Simvastatin—coronary artery disease	0.000143	0.00121	CcSEcCtD
Methylergometrine—Rash—Ezetimibe—coronary artery disease	0.000143	0.00121	CcSEcCtD
Methylergometrine—Dermatitis—Ezetimibe—coronary artery disease	0.000143	0.00121	CcSEcCtD
Methylergometrine—Headache—Ezetimibe—coronary artery disease	0.000142	0.0012	CcSEcCtD
Methylergometrine—Anaphylactic shock—Ramipril—coronary artery disease	0.000142	0.0012	CcSEcCtD
Methylergometrine—Vomiting—Eplerenone—coronary artery disease	0.000141	0.00119	CcSEcCtD
Methylergometrine—Nausea—Fenofibrate—coronary artery disease	0.000141	0.00119	CcSEcCtD
Methylergometrine—Gastrointestinal pain—Furosemide—coronary artery disease	0.00014	0.00118	CcSEcCtD
Methylergometrine—Rash—Eplerenone—coronary artery disease	0.00014	0.00118	CcSEcCtD
Methylergometrine—Dermatitis—Eplerenone—coronary artery disease	0.00014	0.00118	CcSEcCtD
Methylergometrine—Diarrhoea—Valsartan—coronary artery disease	0.00014	0.00118	CcSEcCtD
Methylergometrine—Abdominal pain—Perindopril—coronary artery disease	0.000139	0.00117	CcSEcCtD
Methylergometrine—Palpitations—Lisinopril—coronary artery disease	0.000139	0.00117	CcSEcCtD
Methylergometrine—Diarrhoea—Olmesartan—coronary artery disease	0.000139	0.00117	CcSEcCtD
Methylergometrine—Headache—Eplerenone—coronary artery disease	0.000139	0.00117	CcSEcCtD
Methylergometrine—Nervous system disorder—Ramipril—coronary artery disease	0.000139	0.00117	CcSEcCtD
Methylergometrine—Anaphylactic shock—Timolol—coronary artery disease	0.000139	0.00117	CcSEcCtD
Methylergometrine—Nausea—Clopidogrel—coronary artery disease	0.000138	0.00117	CcSEcCtD
Methylergometrine—Tachycardia—Ramipril—coronary artery disease	0.000138	0.00117	CcSEcCtD
Methylergometrine—Vomiting—Simvastatin—coronary artery disease	0.000138	0.00116	CcSEcCtD
Methylergometrine—Nausea—Lovastatin—coronary artery disease	0.000137	0.00116	CcSEcCtD
Methylergometrine—Hyperhidrosis—Ramipril—coronary artery disease	0.000137	0.00116	CcSEcCtD
Methylergometrine—Rash—Simvastatin—coronary artery disease	0.000137	0.00115	CcSEcCtD
Methylergometrine—Dermatitis—Simvastatin—coronary artery disease	0.000136	0.00115	CcSEcCtD
Methylergometrine—Diarrhoea—Niacin—coronary artery disease	0.000136	0.00115	CcSEcCtD
Methylergometrine—Nervous system disorder—Timolol—coronary artery disease	0.000136	0.00115	CcSEcCtD
Methylergometrine—Headache—Simvastatin—coronary artery disease	0.000136	0.00114	CcSEcCtD
Methylergometrine—Abdominal pain—Furosemide—coronary artery disease	0.000135	0.00114	CcSEcCtD
Methylergometrine—Gastrointestinal pain—Losartan—coronary artery disease	0.000135	0.00114	CcSEcCtD
Methylergometrine—Dizziness—Valsartan—coronary artery disease	0.000135	0.00114	CcSEcCtD
Methylergometrine—Nausea—Ezetimibe—coronary artery disease	0.000135	0.00114	CcSEcCtD
Methylergometrine—Dizziness—Olmesartan—coronary artery disease	0.000135	0.00113	CcSEcCtD
Methylergometrine—Chest pain—Lisinopril—coronary artery disease	0.000134	0.00113	CcSEcCtD
Methylergometrine—Hyperhidrosis—Timolol—coronary artery disease	0.000134	0.00113	CcSEcCtD
Methylergometrine—Diarrhoea—Pravastatin—coronary artery disease	0.000134	0.00113	CcSEcCtD
Methylergometrine—Hypotension—Ramipril—coronary artery disease	0.000132	0.00112	CcSEcCtD
Methylergometrine—Nausea—Eplerenone—coronary artery disease	0.000132	0.00111	CcSEcCtD
Methylergometrine—Dizziness—Niacin—coronary artery disease	0.000131	0.00111	CcSEcCtD
Methylergometrine—Abdominal pain—Losartan—coronary artery disease	0.000131	0.0011	CcSEcCtD
Methylergometrine—Diarrhoea—Trandolapril—coronary artery disease	0.00013	0.0011	CcSEcCtD
Methylergometrine—Vomiting—Valsartan—coronary artery disease	0.00013	0.0011	CcSEcCtD
Methylergometrine—Diarrhoea—Enalapril—coronary artery disease	0.00013	0.00109	CcSEcCtD
Methylergometrine—Hypotension—Timolol—coronary artery disease	0.00013	0.00109	CcSEcCtD
Methylergometrine—Dizziness—Pravastatin—coronary artery disease	0.000129	0.00109	CcSEcCtD
Methylergometrine—Vomiting—Olmesartan—coronary artery disease	0.000129	0.00109	CcSEcCtD
Methylergometrine—Rash—Valsartan—coronary artery disease	0.000129	0.00109	CcSEcCtD
Methylergometrine—Dermatitis—Valsartan—coronary artery disease	0.000129	0.00109	CcSEcCtD
Methylergometrine—Nausea—Simvastatin—coronary artery disease	0.000129	0.00108	CcSEcCtD
Methylergometrine—Anaphylactic shock—Lisinopril—coronary artery disease	0.000129	0.00108	CcSEcCtD
Methylergometrine—Rash—Olmesartan—coronary artery disease	0.000128	0.00108	CcSEcCtD
Methylergometrine—Dermatitis—Olmesartan—coronary artery disease	0.000128	0.00108	CcSEcCtD
Methylergometrine—Headache—Valsartan—coronary artery disease	0.000128	0.00108	CcSEcCtD
Methylergometrine—Diarrhoea—Telmisartan—coronary artery disease	0.000128	0.00108	CcSEcCtD
Methylergometrine—Headache—Olmesartan—coronary artery disease	0.000127	0.00107	CcSEcCtD
Methylergometrine—Paraesthesia—Ramipril—coronary artery disease	0.000127	0.00107	CcSEcCtD
Methylergometrine—Dyspnoea—Ramipril—coronary artery disease	0.000126	0.00107	CcSEcCtD
Methylergometrine—Vomiting—Niacin—coronary artery disease	0.000126	0.00107	CcSEcCtD
Methylergometrine—Dizziness—Trandolapril—coronary artery disease	0.000126	0.00106	CcSEcCtD
Methylergometrine—Tachycardia—Lisinopril—coronary artery disease	0.000125	0.00106	CcSEcCtD
Methylergometrine—Rash—Niacin—coronary artery disease	0.000125	0.00106	CcSEcCtD
Methylergometrine—Dermatitis—Niacin—coronary artery disease	0.000125	0.00106	CcSEcCtD
Methylergometrine—Dizziness—Enalapril—coronary artery disease	0.000125	0.00106	CcSEcCtD
Methylergometrine—Headache—Niacin—coronary artery disease	0.000125	0.00105	CcSEcCtD
Methylergometrine—Paraesthesia—Timolol—coronary artery disease	0.000124	0.00105	CcSEcCtD
Methylergometrine—Vomiting—Pravastatin—coronary artery disease	0.000124	0.00105	CcSEcCtD
Methylergometrine—Hyperhidrosis—Lisinopril—coronary artery disease	0.000124	0.00105	CcSEcCtD
Methylergometrine—Diarrhoea—Captopril—coronary artery disease	0.000124	0.00105	CcSEcCtD
Methylergometrine—Dyspnoea—Timolol—coronary artery disease	0.000124	0.00104	CcSEcCtD
Methylergometrine—Dizziness—Telmisartan—coronary artery disease	0.000123	0.00104	CcSEcCtD
Methylergometrine—Rash—Pravastatin—coronary artery disease	0.000123	0.00104	CcSEcCtD
Methylergometrine—Dermatitis—Pravastatin—coronary artery disease	0.000123	0.00104	CcSEcCtD
Methylergometrine—Headache—Pravastatin—coronary artery disease	0.000123	0.00103	CcSEcCtD
Methylergometrine—Nausea—Valsartan—coronary artery disease	0.000121	0.00102	CcSEcCtD
Methylergometrine—Nausea—Olmesartan—coronary artery disease	0.000121	0.00102	CcSEcCtD
Methylergometrine—Vomiting—Trandolapril—coronary artery disease	0.000121	0.00102	CcSEcCtD
Methylergometrine—Diarrhoea—Perindopril—coronary artery disease	0.000121	0.00102	CcSEcCtD
Methylergometrine—Vomiting—Enalapril—coronary artery disease	0.00012	0.00101	CcSEcCtD
Methylergometrine—Hypotension—Lisinopril—coronary artery disease	0.00012	0.00101	CcSEcCtD
Methylergometrine—Dizziness—Captopril—coronary artery disease	0.00012	0.00101	CcSEcCtD
Methylergometrine—Rash—Trandolapril—coronary artery disease	0.00012	0.00101	CcSEcCtD
Methylergometrine—Dermatitis—Trandolapril—coronary artery disease	0.00012	0.00101	CcSEcCtD
Methylergometrine—Rash—Enalapril—coronary artery disease	0.000119	0.00101	CcSEcCtD
Methylergometrine—Dermatitis—Enalapril—coronary artery disease	0.000119	0.00101	CcSEcCtD
Methylergometrine—Headache—Trandolapril—coronary artery disease	0.000119	0.001	CcSEcCtD
Methylergometrine—Vomiting—Telmisartan—coronary artery disease	0.000119	0.001	CcSEcCtD
Methylergometrine—Headache—Enalapril—coronary artery disease	0.000119	0.001	CcSEcCtD
Methylergometrine—Nausea—Niacin—coronary artery disease	0.000118	0.000995	CcSEcCtD
Methylergometrine—Rash—Telmisartan—coronary artery disease	0.000118	0.000992	CcSEcCtD
Methylergometrine—Dermatitis—Telmisartan—coronary artery disease	0.000118	0.000991	CcSEcCtD
Methylergometrine—Diarrhoea—Furosemide—coronary artery disease	0.000117	0.000988	CcSEcCtD
Methylergometrine—Headache—Telmisartan—coronary artery disease	0.000117	0.000986	CcSEcCtD
Methylergometrine—Dizziness—Perindopril—coronary artery disease	0.000117	0.000983	CcSEcCtD
Methylergometrine—Nausea—Pravastatin—coronary artery disease	0.000116	0.00098	CcSEcCtD
Methylergometrine—Gastrointestinal pain—Ramipril—coronary artery disease	0.000116	0.000977	CcSEcCtD
Methylergometrine—Paraesthesia—Lisinopril—coronary artery disease	0.000115	0.000973	CcSEcCtD
Methylergometrine—Vomiting—Captopril—coronary artery disease	0.000115	0.000973	CcSEcCtD
Methylergometrine—Dyspnoea—Lisinopril—coronary artery disease	0.000115	0.000966	CcSEcCtD
Methylergometrine—Rash—Captopril—coronary artery disease	0.000114	0.000965	CcSEcCtD
Methylergometrine—Dermatitis—Captopril—coronary artery disease	0.000114	0.000964	CcSEcCtD
Methylergometrine—Headache—Captopril—coronary artery disease	0.000114	0.000959	CcSEcCtD
Methylergometrine—Gastrointestinal pain—Timolol—coronary artery disease	0.000113	0.000955	CcSEcCtD
Methylergometrine—Dizziness—Furosemide—coronary artery disease	0.000113	0.000955	CcSEcCtD
Methylergometrine—Diarrhoea—Losartan—coronary artery disease	0.000113	0.000954	CcSEcCtD
Methylergometrine—Nausea—Trandolapril—coronary artery disease	0.000113	0.000952	CcSEcCtD
Methylergometrine—Nausea—Enalapril—coronary artery disease	0.000112	0.000948	CcSEcCtD
Methylergometrine—Vomiting—Perindopril—coronary artery disease	0.000112	0.000945	CcSEcCtD
Methylergometrine—Abdominal pain—Ramipril—coronary artery disease	0.000112	0.000945	CcSEcCtD
Methylergometrine—Rash—Perindopril—coronary artery disease	0.000111	0.000937	CcSEcCtD
Methylergometrine—Dermatitis—Perindopril—coronary artery disease	0.000111	0.000936	CcSEcCtD
Methylergometrine—Nausea—Telmisartan—coronary artery disease	0.000111	0.000935	CcSEcCtD
Methylergometrine—Headache—Perindopril—coronary artery disease	0.00011	0.000931	CcSEcCtD
Methylergometrine—Abdominal pain—Timolol—coronary artery disease	0.00011	0.000924	CcSEcCtD
Methylergometrine—Dizziness—Losartan—coronary artery disease	0.000109	0.000922	CcSEcCtD
Methylergometrine—Vomiting—Furosemide—coronary artery disease	0.000109	0.000919	CcSEcCtD
Methylergometrine—Rash—Furosemide—coronary artery disease	0.000108	0.000911	CcSEcCtD
Methylergometrine—Dermatitis—Furosemide—coronary artery disease	0.000108	0.00091	CcSEcCtD
Methylergometrine—Nausea—Captopril—coronary artery disease	0.000108	0.000909	CcSEcCtD
Methylergometrine—Headache—Furosemide—coronary artery disease	0.000107	0.000905	CcSEcCtD
Methylergometrine—Gastrointestinal pain—Lisinopril—coronary artery disease	0.000105	0.000886	CcSEcCtD
Methylergometrine—Vomiting—Losartan—coronary artery disease	0.000105	0.000886	CcSEcCtD
Methylergometrine—Nausea—Perindopril—coronary artery disease	0.000105	0.000883	CcSEcCtD
Methylergometrine—Rash—Losartan—coronary artery disease	0.000104	0.000879	CcSEcCtD
Methylergometrine—Dermatitis—Losartan—coronary artery disease	0.000104	0.000878	CcSEcCtD
Methylergometrine—Headache—Losartan—coronary artery disease	0.000104	0.000873	CcSEcCtD
Methylergometrine—Nausea—Furosemide—coronary artery disease	0.000102	0.000858	CcSEcCtD
Methylergometrine—Abdominal pain—Lisinopril—coronary artery disease	0.000102	0.000857	CcSEcCtD
Methylergometrine—Nausea—Losartan—coronary artery disease	9.82e-05	0.000828	CcSEcCtD
Methylergometrine—Diarrhoea—Ramipril—coronary artery disease	9.7e-05	0.000818	CcSEcCtD
Methylergometrine—Diarrhoea—Timolol—coronary artery disease	9.48e-05	0.000799	CcSEcCtD
Methylergometrine—Dizziness—Ramipril—coronary artery disease	9.38e-05	0.00079	CcSEcCtD
Methylergometrine—Dizziness—Timolol—coronary artery disease	9.17e-05	0.000773	CcSEcCtD
Methylergometrine—Vomiting—Ramipril—coronary artery disease	9.01e-05	0.00076	CcSEcCtD
Methylergometrine—Rash—Ramipril—coronary artery disease	8.94e-05	0.000754	CcSEcCtD
Methylergometrine—Dermatitis—Ramipril—coronary artery disease	8.93e-05	0.000753	CcSEcCtD
Methylergometrine—Headache—Ramipril—coronary artery disease	8.88e-05	0.000749	CcSEcCtD
Methylergometrine—Vomiting—Timolol—coronary artery disease	8.81e-05	0.000743	CcSEcCtD
Methylergometrine—Diarrhoea—Lisinopril—coronary artery disease	8.8e-05	0.000742	CcSEcCtD
Methylergometrine—Rash—Timolol—coronary artery disease	8.74e-05	0.000737	CcSEcCtD
Methylergometrine—Dermatitis—Timolol—coronary artery disease	8.73e-05	0.000736	CcSEcCtD
Methylergometrine—Headache—Timolol—coronary artery disease	8.68e-05	0.000732	CcSEcCtD
Methylergometrine—Dizziness—Lisinopril—coronary artery disease	8.5e-05	0.000717	CcSEcCtD
Methylergometrine—Nausea—Ramipril—coronary artery disease	8.42e-05	0.00071	CcSEcCtD
Methylergometrine—Nausea—Timolol—coronary artery disease	8.23e-05	0.000694	CcSEcCtD
Methylergometrine—Vomiting—Lisinopril—coronary artery disease	8.18e-05	0.000689	CcSEcCtD
Methylergometrine—Rash—Lisinopril—coronary artery disease	8.11e-05	0.000683	CcSEcCtD
Methylergometrine—Dermatitis—Lisinopril—coronary artery disease	8.1e-05	0.000683	CcSEcCtD
Methylergometrine—Headache—Lisinopril—coronary artery disease	8.06e-05	0.000679	CcSEcCtD
Methylergometrine—Nausea—Lisinopril—coronary artery disease	7.64e-05	0.000644	CcSEcCtD
Methylergometrine—HTR2B—Signaling Pathways—F2—coronary artery disease	4.38e-06	4.75e-05	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—APOE—coronary artery disease	4.38e-06	4.75e-05	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—LEP—coronary artery disease	4.38e-06	4.75e-05	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—PDHA1—coronary artery disease	4.37e-06	4.73e-05	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—GCLM—coronary artery disease	4.37e-06	4.73e-05	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—IL6ST—coronary artery disease	4.36e-06	4.73e-05	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—SOCS3—coronary artery disease	4.36e-06	4.72e-05	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling by GPCR—AKT1—coronary artery disease	4.34e-06	4.71e-05	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—APOA1—coronary artery disease	4.33e-06	4.69e-05	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—NFKBIA—coronary artery disease	4.33e-06	4.69e-05	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—ITGB3—coronary artery disease	4.32e-06	4.68e-05	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—TGFBR2—coronary artery disease	4.3e-06	4.67e-05	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—KITLG—coronary artery disease	4.3e-06	4.67e-05	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—KDR—coronary artery disease	4.29e-06	4.65e-05	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—MAPK14—coronary artery disease	4.26e-06	4.62e-05	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling Pathways—VEGFA—coronary artery disease	4.26e-06	4.62e-05	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—TXNRD1—coronary artery disease	4.23e-06	4.58e-05	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—CYP11B2—coronary artery disease	4.23e-06	4.58e-05	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling by GPCR—CXCL8—coronary artery disease	4.22e-06	4.57e-05	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—MMP3—coronary artery disease	4.21e-06	4.56e-05	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—STAT5A—coronary artery disease	4.21e-06	4.56e-05	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—PPP2CA—coronary artery disease	4.2e-06	4.55e-05	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—KIT—coronary artery disease	4.19e-06	4.54e-05	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—ESR1—coronary artery disease	4.18e-06	4.53e-05	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—SLC22A3—coronary artery disease	4.17e-06	4.52e-05	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—F2—coronary artery disease	4.13e-06	4.48e-05	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—FN1—coronary artery disease	4.13e-06	4.48e-05	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—PRKCD—coronary artery disease	4.12e-06	4.47e-05	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—IL6ST—coronary artery disease	4.12e-06	4.46e-05	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—ARNTL—coronary artery disease	4.11e-06	4.45e-05	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—HADH—coronary artery disease	4.11e-06	4.45e-05	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—NFKBIA—coronary artery disease	4.08e-06	4.43e-05	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—APOB—coronary artery disease	4.07e-06	4.41e-05	CbGpPWpGaD
Methylergometrine—HTR2A—GPCR downstream signaling—CXCL8—coronary artery disease	4.03e-06	4.37e-05	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—HTR2A—coronary artery disease	4.03e-06	4.37e-05	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—C3—coronary artery disease	4.03e-06	4.36e-05	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—GSK3B—coronary artery disease	4.02e-06	4.36e-05	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—VEGFA—coronary artery disease	4.02e-06	4.36e-05	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling by GPCR—JAK2—coronary artery disease	4.01e-06	4.35e-05	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—EDN1—coronary artery disease	4e-06	4.34e-05	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—POMC—coronary artery disease	3.99e-06	4.33e-05	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—CREB1—coronary artery disease	3.99e-06	4.33e-05	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—CCL5—coronary artery disease	3.97e-06	4.3e-05	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—KIT—coronary artery disease	3.95e-06	4.29e-05	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling Pathways—TGFB1—coronary artery disease	3.91e-06	4.24e-05	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—FGF1—coronary artery disease	3.91e-06	4.24e-05	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—CSF2—coronary artery disease	3.91e-06	4.24e-05	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—CCL2—coronary artery disease	3.91e-06	4.23e-05	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—IL6R—coronary artery disease	3.89e-06	4.22e-05	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—APOA2—coronary artery disease	3.89e-06	4.22e-05	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—PLA2G2A—coronary artery disease	3.89e-06	4.22e-05	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—GPX2—coronary artery disease	3.89e-06	4.22e-05	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—LPL—coronary artery disease	3.88e-06	4.21e-05	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—MEF2C—coronary artery disease	3.85e-06	4.17e-05	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—RPS6KB1—coronary artery disease	3.85e-06	4.17e-05	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—SULT1A1—coronary artery disease	3.84e-06	4.17e-05	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—HK1—coronary artery disease	3.84e-06	4.17e-05	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—GPX4—coronary artery disease	3.84e-06	4.17e-05	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—ABCG5—coronary artery disease	3.84e-06	4.17e-05	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—HIF1A—coronary artery disease	3.84e-06	4.16e-05	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—IGF1—coronary artery disease	3.84e-06	4.16e-05	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling Pathways—MAPK1—coronary artery disease	3.84e-06	4.16e-05	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—AGT—coronary artery disease	3.83e-06	4.15e-05	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling by GPCR—MAPK1—coronary artery disease	3.82e-06	4.14e-05	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—HADHA—coronary artery disease	3.8e-06	4.12e-05	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—GSK3B—coronary artery disease	3.79e-06	4.11e-05	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—POMC—coronary artery disease	3.76e-06	4.08e-05	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—CREB1—coronary artery disease	3.76e-06	4.08e-05	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—GSTA1—coronary artery disease	3.75e-06	4.07e-05	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—ITGB3—coronary artery disease	3.75e-06	4.06e-05	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—LEP—coronary artery disease	3.75e-06	4.06e-05	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—APOE—coronary artery disease	3.75e-06	4.06e-05	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—LPA—coronary artery disease	3.71e-06	4.02e-05	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—APOA1—coronary artery disease	3.71e-06	4.02e-05	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—TGFB1—coronary artery disease	3.69e-06	4e-05	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—CCL2—coronary artery disease	3.68e-06	3.99e-05	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—KDR—coronary artery disease	3.67e-06	3.98e-05	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—IL6R—coronary artery disease	3.67e-06	3.98e-05	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling by GPCR—CXCL8—coronary artery disease	3.66e-06	3.97e-05	CbGpPWpGaD
Methylergometrine—HTR2B—GPCR downstream signaling—PIK3CA—coronary artery disease	3.65e-06	3.96e-05	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—MAPK14—coronary artery disease	3.65e-06	3.95e-05	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—SERPINE1—coronary artery disease	3.65e-06	3.95e-05	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—PPP2CA—coronary artery disease	3.64e-06	3.95e-05	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—IGF1—coronary artery disease	3.62e-06	3.92e-05	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—MAPK1—coronary artery disease	3.62e-06	3.92e-05	CbGpPWpGaD
Methylergometrine—DRD1—Signaling by GPCR—MAPK1—coronary artery disease	3.6e-06	3.91e-05	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—PLCB3—coronary artery disease	3.6e-06	3.9e-05	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—ESR1—coronary artery disease	3.58e-06	3.88e-05	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—PRKCD—coronary artery disease	3.58e-06	3.88e-05	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—APOA5—coronary artery disease	3.56e-06	3.86e-05	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—F2—coronary artery disease	3.53e-06	3.83e-05	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—FN1—coronary artery disease	3.53e-06	3.83e-05	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—FGF2—coronary artery disease	3.53e-06	3.83e-05	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—IL6ST—coronary artery disease	3.52e-06	3.82e-05	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—C3—coronary artery disease	3.5e-06	3.79e-05	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—NFKBIA—coronary artery disease	3.49e-06	3.79e-05	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—P4HB—coronary artery disease	3.49e-06	3.78e-05	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—NOS3—coronary artery disease	3.48e-06	3.77e-05	CbGpPWpGaD
Methylergometrine—DRD1—GPCR downstream signaling—PIK3CA—coronary artery disease	3.44e-06	3.73e-05	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—SERPINE1—coronary artery disease	3.44e-06	3.73e-05	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—PLA2G1B—coronary artery disease	3.43e-06	3.71e-05	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—JAK2—coronary artery disease	3.38e-06	3.67e-05	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—KIT—coronary artery disease	3.38e-06	3.67e-05	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—HIF1A—coronary artery disease	3.33e-06	3.61e-05	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling Pathways—PIK3CA—coronary artery disease	3.33e-06	3.61e-05	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—FGF2—coronary artery disease	3.33e-06	3.61e-05	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—AGT—coronary artery disease	3.32e-06	3.6e-05	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling by GPCR—PIK3CA—coronary artery disease	3.32e-06	3.59e-05	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—NOS3—coronary artery disease	3.28e-06	3.56e-05	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—LEP—coronary artery disease	3.25e-06	3.53e-05	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—APOE—coronary artery disease	3.25e-06	3.53e-05	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—GSK3B—coronary artery disease	3.25e-06	3.52e-05	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—VCAN—coronary artery disease	3.23e-06	3.5e-05	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—POMC—coronary artery disease	3.22e-06	3.49e-05	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—CREB1—coronary artery disease	3.22e-06	3.49e-05	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—APOA1—coronary artery disease	3.22e-06	3.49e-05	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—ALDOA—coronary artery disease	3.21e-06	3.47e-05	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—JAK2—coronary artery disease	3.19e-06	3.46e-05	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—KDR—coronary artery disease	3.19e-06	3.46e-05	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—MAPK14—coronary artery disease	3.17e-06	3.43e-05	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—CCL2—coronary artery disease	3.15e-06	3.41e-05	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—PIK3CA—coronary artery disease	3.14e-06	3.4e-05	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—IL6R—coronary artery disease	3.14e-06	3.4e-05	CbGpPWpGaD
Methylergometrine—DRD1—Signaling by GPCR—PIK3CA—coronary artery disease	3.13e-06	3.39e-05	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—DCN—coronary artery disease	3.11e-06	3.37e-05	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—ESR1—coronary artery disease	3.11e-06	3.37e-05	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—IGF1—coronary artery disease	3.1e-06	3.36e-05	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—CXCL8—coronary artery disease	3.09e-06	3.35e-05	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling by GPCR—MAPK1—coronary artery disease	3.08e-06	3.34e-05	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—F2—coronary artery disease	3.07e-06	3.33e-05	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—FN1—coronary artery disease	3.07e-06	3.33e-05	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—IL6ST—coronary artery disease	3.06e-06	3.31e-05	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—NFKBIA—coronary artery disease	3.03e-06	3.29e-05	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—ALDH2—coronary artery disease	3.03e-06	3.28e-05	CbGpPWpGaD
Methylergometrine—HTR2B—GPCR downstream signaling—AKT1—coronary artery disease	2.98e-06	3.23e-05	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—CASP3—coronary artery disease	2.96e-06	3.2e-05	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—LIPC—coronary artery disease	2.95e-06	3.2e-05	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—CYP2C19—coronary artery disease	2.95e-06	3.2e-05	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—PIK3C2A—coronary artery disease	2.95e-06	3.2e-05	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—HBA1—coronary artery disease	2.95e-06	3.2e-05	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling Pathways—IL6—coronary artery disease	2.95e-06	3.2e-05	CbGpPWpGaD
Methylergometrine—HTR2C—GPCR downstream signaling—PIK3CA—coronary artery disease	2.95e-06	3.19e-05	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—SERPINE1—coronary artery disease	2.94e-06	3.19e-05	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—KIT—coronary artery disease	2.94e-06	3.18e-05	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling by GPCR—IL6—coronary artery disease	2.94e-06	3.18e-05	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—APOC3—coronary artery disease	2.93e-06	3.18e-05	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—LDLR—coronary artery disease	2.91e-06	3.16e-05	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—CXCL8—coronary artery disease	2.91e-06	3.16e-05	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—SLC9A1—coronary artery disease	2.88e-06	3.12e-05	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—GSTT1—coronary artery disease	2.88e-06	3.12e-05	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—CCND1—coronary artery disease	2.88e-06	3.12e-05	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—FGF2—coronary artery disease	2.85e-06	3.09e-05	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—GCLC—coronary artery disease	2.85e-06	3.08e-05	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—CETP—coronary artery disease	2.85e-06	3.08e-05	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—GSK3B—coronary artery disease	2.82e-06	3.06e-05	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—SDC1—coronary artery disease	2.81e-06	3.05e-05	CbGpPWpGaD
Methylergometrine—DRD1—GPCR downstream signaling—AKT1—coronary artery disease	2.81e-06	3.05e-05	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—NOS3—coronary artery disease	2.81e-06	3.04e-05	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—POMC—coronary artery disease	2.8e-06	3.03e-05	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—CREB1—coronary artery disease	2.8e-06	3.03e-05	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—MMP9—coronary artery disease	2.79e-06	3.03e-05	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—CASP3—coronary artery disease	2.79e-06	3.02e-05	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—IL6—coronary artery disease	2.78e-06	3.01e-05	CbGpPWpGaD
Methylergometrine—DRD1—Signaling by GPCR—IL6—coronary artery disease	2.77e-06	3e-05	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—CCL2—coronary artery disease	2.74e-06	2.97e-05	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—JAK2—coronary artery disease	2.73e-06	2.96e-05	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—IL6R—coronary artery disease	2.73e-06	2.96e-05	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling Pathways—AKT1—coronary artery disease	2.72e-06	2.95e-05	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—CCND1—coronary artery disease	2.71e-06	2.94e-05	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling by GPCR—AKT1—coronary artery disease	2.71e-06	2.94e-05	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—IGF1—coronary artery disease	2.69e-06	2.92e-05	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling by GPCR—MAPK1—coronary artery disease	2.68e-06	2.9e-05	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling by GPCR—PIK3CA—coronary artery disease	2.67e-06	2.9e-05	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—PSMA6—coronary artery disease	2.66e-06	2.88e-05	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—PSMB5—coronary artery disease	2.66e-06	2.88e-05	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—MMP9—coronary artery disease	2.63e-06	2.85e-05	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—CTGF—coronary artery disease	2.6e-06	2.81e-05	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—HMGCR—coronary artery disease	2.57e-06	2.79e-05	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—GOT2—coronary artery disease	2.57e-06	2.79e-05	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—AKT1—coronary artery disease	2.57e-06	2.78e-05	CbGpPWpGaD
Methylergometrine—HTR2A—GPCR downstream signaling—PIK3CA—coronary artery disease	2.56e-06	2.77e-05	CbGpPWpGaD
Methylergometrine—DRD1—Signaling by GPCR—AKT1—coronary artery disease	2.55e-06	2.77e-05	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—SERPINE1—coronary artery disease	2.55e-06	2.77e-05	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—VEGFA—coronary artery disease	2.51e-06	2.72e-05	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—CXCL8—coronary artery disease	2.49e-06	2.7e-05	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—FGF2—coronary artery disease	2.47e-06	2.68e-05	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—NOS3—coronary artery disease	2.44e-06	2.64e-05	CbGpPWpGaD
Methylergometrine—HTR2C—GPCR downstream signaling—AKT1—coronary artery disease	2.41e-06	2.61e-05	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—CASP3—coronary artery disease	2.38e-06	2.58e-05	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—JAK2—coronary artery disease	2.37e-06	2.57e-05	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling by GPCR—IL6—coronary artery disease	2.37e-06	2.57e-05	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—PLCB1—coronary artery disease	2.37e-06	2.57e-05	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—VEGFA—coronary artery disease	2.36e-06	2.56e-05	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling by GPCR—PIK3CA—coronary artery disease	2.32e-06	2.52e-05	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—CCND1—coronary artery disease	2.32e-06	2.52e-05	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—TGFB1—coronary artery disease	2.3e-06	2.49e-05	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—ABCA1—coronary artery disease	2.29e-06	2.49e-05	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—MAPK1—coronary artery disease	2.26e-06	2.45e-05	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—MMP9—coronary artery disease	2.25e-06	2.44e-05	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—GOT1—coronary artery disease	2.22e-06	2.41e-05	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—GGT1—coronary artery disease	2.22e-06	2.41e-05	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling by GPCR—AKT1—coronary artery disease	2.19e-06	2.37e-05	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—TGFB1—coronary artery disease	2.17e-06	2.35e-05	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—CXCL8—coronary artery disease	2.16e-06	2.34e-05	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—MAPK1—coronary artery disease	2.13e-06	2.31e-05	CbGpPWpGaD
Methylergometrine—HTR2A—GPCR downstream signaling—AKT1—coronary artery disease	2.09e-06	2.26e-05	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—CASP3—coronary artery disease	2.07e-06	2.24e-05	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling by GPCR—IL6—coronary artery disease	2.06e-06	2.23e-05	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—VEGFA—coronary artery disease	2.02e-06	2.19e-05	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—CCND1—coronary artery disease	2.02e-06	2.18e-05	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—GSTP1—coronary artery disease	2e-06	2.16e-05	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—PPARGC1A—coronary artery disease	1.98e-06	2.14e-05	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—HMOX1—coronary artery disease	1.97e-06	2.13e-05	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—PIK3CA—coronary artery disease	1.96e-06	2.12e-05	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—MMP9—coronary artery disease	1.96e-06	2.12e-05	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—CAT—coronary artery disease	1.94e-06	2.1e-05	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling by GPCR—AKT1—coronary artery disease	1.9e-06	2.06e-05	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—APOB—coronary artery disease	1.89e-06	2.04e-05	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—TGFB1—coronary artery disease	1.86e-06	2.01e-05	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—PIK3CA—coronary artery disease	1.85e-06	2e-05	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—GSTM1—coronary artery disease	1.83e-06	1.99e-05	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—MAPK1—coronary artery disease	1.82e-06	1.97e-05	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—LPL—coronary artery disease	1.8e-06	1.95e-05	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—VEGFA—coronary artery disease	1.76e-06	1.9e-05	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—GPX1—coronary artery disease	1.76e-06	1.9e-05	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—IL6—coronary artery disease	1.73e-06	1.88e-05	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—CD36—coronary artery disease	1.71e-06	1.85e-05	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—PPP2CA—coronary artery disease	1.69e-06	1.83e-05	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—IL6—coronary artery disease	1.64e-06	1.77e-05	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—MTHFR—coronary artery disease	1.62e-06	1.76e-05	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—TGFB1—coronary artery disease	1.61e-06	1.75e-05	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—AKT1—coronary artery disease	1.6e-06	1.73e-05	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—MAPK1—coronary artery disease	1.58e-06	1.71e-05	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—PIK3CA—coronary artery disease	1.58e-06	1.71e-05	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—AGT—coronary artery disease	1.54e-06	1.67e-05	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—AKT1—coronary artery disease	1.51e-06	1.64e-05	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—APOE—coronary artery disease	1.51e-06	1.64e-05	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—APOA1—coronary artery disease	1.49e-06	1.62e-05	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—IL6—coronary artery disease	1.4e-06	1.52e-05	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—PIK3CA—coronary artery disease	1.37e-06	1.49e-05	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—PPARG—coronary artery disease	1.31e-06	1.42e-05	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—POMC—coronary artery disease	1.3e-06	1.4e-05	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—AKT1—coronary artery disease	1.29e-06	1.4e-05	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—IL6—coronary artery disease	1.22e-06	1.32e-05	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—ALB—coronary artery disease	1.18e-06	1.28e-05	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—NOS3—coronary artery disease	1.13e-06	1.23e-05	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—AKT1—coronary artery disease	1.12e-06	1.21e-05	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—PTGS2—coronary artery disease	1.03e-06	1.12e-05	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—PIK3CA—coronary artery disease	6.36e-07	6.89e-06	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—AKT1—coronary artery disease	5.2e-07	5.63e-06	CbGpPWpGaD
